Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal

Giuseppe Castellano1, Rita Melchiorre, Antonia Loverre

  • 1Department of Emergency and Organ Transplantation, University of Bari, Policlinico, Piazza Giulio Cesare 11, Bari, Italy. g.castellano@nephro.uniba.it

Insights

Kidney transplant ischemia-reperfusion injury involves complement pathways. Inhibiting classical and lectin pathways reduces damage and may prevent delayed graft function.

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation

Background:

  • Ischemia-reperfusion injury (IRI) is a primary cause of delayed graft function in kidney transplantation.
  • The alternative complement pathway's role in IRI is known in rodents, but human and large animal data are limited.

Purpose of the Study:

  • To investigate the role of complement pathways in renal IRI using a swine model.
  • To evaluate the therapeutic potential of C1-inhibitor in mitigating IRI-induced kidney damage.

Main Methods:

  • A swine model of renal IRI was established.
  • Complement deposition (C4d/C1q, C4d/MLB, MBL/MASP-2) was assessed post-ischemia.
  • C1-inhibitor was administered to assess its effects on complement deposition, immune cell infiltration, tubular damage, and apoptosis.
  • Human kidney transplant biopsies with delayed graft function were analyzed for complement deposition.

Main Results:

  • Ischemia induced C4d/C1q, C4d/MLB, and MBL/MASP-2 deposition in swine kidneys.
  • C1-inhibitor treatment significantly reduced C4d and C5b-9 deposition, immune cell infiltration, tubular damage, and apoptosis.
  • Focal C4d deposition co-localized with C1q and MBL in human delayed graft function biopsies.

Conclusions:

  • The classical and lectin complement pathways are activated and play a pathogenic role in swine renal IRI.
  • C1-inhibitor effectively mitigates IRI-induced renal damage in a large animal model.
  • Inhibiting these complement pathways may offer a novel therapeutic strategy for preventing delayed graft function in kidney transplant recipients.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...